Alimera Sciences Correlations

ALIMDelisted Stock  USD 5.54  0.01  0.18%   
The current 90-days correlation between Alimera Sciences and Lifecore Biomedical is -0.07 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alimera Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alimera Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Alimera Sciences Correlation With Market

Average diversification

The correlation between Alimera Sciences and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alimera Sciences and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Moving against Alimera Stock

  0.65BA Boeing Fiscal Year End 29th of January 2025 PairCorr
  0.59EC Ecopetrol SA ADRPairCorr
  0.55BKRKF PT Bank RakyatPairCorr
  0.4PPERF Bank Mandiri PerseroPairCorr
  0.35JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.34KO Coca Cola Sell-off TrendPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ADMPLSDI
ATNXLSDI
ATNXADMP
ATNXMNK
ADMPMNK
ORGOLFCR
  
High negative correlations   
MMNFFADMP
MMNFFLSDI
MMNFFATNX
MMNFFMNK
LSDIDERM
ADMPDERM

Risk-Adjusted Indicators

There is a big difference between Alimera Stock performing well and Alimera Sciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alimera Sciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SHPH  5.23 (1.06) 0.00  3.49  0.00 
 10.08 
 50.96 
LFCR  3.64  0.67  0.13  0.63  4.48 
 9.76 
 25.69 
MNK  16.59  1.52  0.10  2.49  13.99 
 12.50 
 504.19 
DERM  3.08 (0.02) 0.01  0.10  3.94 
 6.89 
 22.80 
LSDI  298.43  150.99  3.23  67.34  27.98 
 550.00 
 3,998 
ADMP  4.75 (1.64) 0.00  1.55  0.00 
 8.72 
 40.76 
ORGO  3.05  0.24  0.12  0.21  3.23 
 7.55 
 37.89 
CYTH  3.33 (0.09) 0.00 (0.63) 0.00 
 5.33 
 25.00 
ATNX  13.35 (3.88) 0.00  7.10  0.00 
 25.00 
 143.13 
MMNFF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Alimera Sciences Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alimera Sciences stock to make a market-neutral strategy. Peer analysis of Alimera Sciences could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Alimera Sciences Corporate Executives

Elected by the shareholders, the Alimera Sciences' board of directors comprises two types of representatives: Alimera Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alimera. The board's role is to monitor Alimera Sciences' management team and ensure that shareholders' interests are well served. Alimera Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alimera Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
David HollandCo-Founder and Sr. VP of Sales and MarketingProfile
Richard EiswirthPres and CFOProfile
Elliot CPACFO TreasurerProfile

Still Interested in Alimera Sciences?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.